Rascol, O, Brooks, DJ, Korczyn, AD, et al.
A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. N Engl J Med
Parkinson Study Group. Pramipexole vs. levodopa as initial treatment for Parkinson’s disease. A randomized controlled trial. JAMA
Lees, AJ, Katzenschlager, R, Head, J, Ben Shlomo, Y.
Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial. Neurology
Marek, K, Seibyl, J, Shoulson, I, et al.
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson’s disease progression. JAMA
Whone, AL, Remy, P, Davis, MR, et al.
The REAL-PETstudy: slower progression in early Parkinson’s disease treated with ropinirole compared with L-dopa. Neurology
Sanjiv, CC, Schulzer, M, Mak, E, et al.
Daytime somnolence in patients with Parkinson’s disease. Parkinsonism & Related Disorders
2001; 7: 283–286.
Hobson, DE, Lang, AE, Martin, WR, et al.
Excessive daytime sleepiness and sudden-onset sleep in Parkinson’s disease: a survey by the Canadian Movement Disorders Group. JAMA
Guttman, M, Slaughter, PM, Theriault, M-E, DeBoer, DP, Naylor, CD.
Parkinsonism in Ontario: physician utilization. Can J Neurol Sci
Frequency and cause of Parkinson’s disease. Can J Neurol Sci
1992; 19 (Suppl. 1):103–107.